Global Journal of Surgery
ISSN (Print): 2379-8742 ISSN (Online): 2379-8750 Website: http://www.sciepub.com/journal/js Editor-in-chief: Baki Topal
Open Access
Journal Browser
Go
Global Journal of Surgery. 2015, 3(2), 27-30
DOI: 10.12691/js-3-2-3
Open AccessArticle

Extracapsular Dissection versus Superficial Parotidectomy for Treatment of Benign Parotid Tumors

Mohamed Korany1, and Ahmed Said2

1Department of Surgery, Assiut University, Egypt

2Department of Surgical Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

Pub. Date: October 15, 2015

Cite this paper:
Mohamed Korany and Ahmed Said. Extracapsular Dissection versus Superficial Parotidectomy for Treatment of Benign Parotid Tumors. Global Journal of Surgery. 2015; 3(2):27-30. doi: 10.12691/js-3-2-3

Abstract

Objective: The current study aimed to compare extracapsular dissection (ED) versus superficial parotidectomy (SP) in surgical treatment of benign parotid tumors. Methodology: Thirty two patients with benign parotid tumors were included in this study. The patients divided into two groups: the ED group (16) patients (5 males and 11 females) and SP group 16 patients (7 males and 9 females). Patients were followed up for 2 years. Results: Sixteen were included in (ED) group and 16 in (SP) group, twelve patients were males (37.5%) and 20 patients were females (62.5%). The mean age was 47.2 years (range 21 to 69 years) in both groups. No complications developed in (ED) group except wound infections in 2 patients (12.5%). Many cases complicated in (SP) group: two cases of temporary facial paresis, (12.5%), 3 cases of salivary fistula (18.7%), 10 cases (62.5) of cosmetic deformity in the form of depressions in the parotid region and one patient (6.2%) developed Frey's syndrome. No recurrence in either group. Conclusion: Extracapsular dissection is safe and reliable procedure compared to superficial parotidectomy with reduced morbidity and good cosmetic results.

Keywords:
extracapsular dissection parotid superficial parotidectomy

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Smith SL, Komisar A. Limited parotidectomy the role of extra capsular dissection in parotid gland neoplasms. Laryngoscope. 2007; 117: 1163-7.
 
[2]  Leverstein H, Van der Wal JE, Tiwari RM. Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br. J Surg. 1997; 84: 399-403.
 
[3]  Woods JE, Chong GC, Beahrs OH. Experience with 1,360 primary parotid tumors. Am. J Surg. 1975; 130: 460-2.
 
[4]  Renehan A, Gleave EN, Hancok BD. Long term follow up of over 1000 patients with salivary gland tumors treated in a single center. Br. J Surg. 1996; 83: 1750-4.
 
[5]  Long don J. The significance of the tumor capsule in pleomorphic adenoma: the changing face of conventional principles. In controversies in the management of salivary gland disease, McGurk M, Remehan AG (eds) pp. 67-73. Oxford 2001; Oxford University press.
 
[6]  Leave G. An alternative to superficial parotidectomy: extracapsular dissection. In colour Atlas and Text of salivary glands: Diseases, Disorders and surgery, de Burgh Norman J, McGurk M. (eds) pp 165-72. London 1995 Mosby-wolf.
 
[7]  Lawson HH: Capsular penetration and perforation in pleomorphic adenoma of the parotid salivary gland. Br. J Surg. 1989; 76: 594-6.
 
[8]  Patey DH, Thackary AC. The treatment of parotid tumors in the light of a pathological study of parotidectomy material. Br. J Surg. 1958; 45: 477-87.
 
[9]  Janes RM. The treatment of tumors of the salivary gland by radical excision. Can. Med. Assoc. J 1940; 43: 554-9.
 
[10]  Guntinas-Lichius O, Kick C. Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy. Eur. Arch. Otorhinolaryng. 2014; 261: 143-6.
 
[11]  Zernial O, Springer IN, Warnke P. Long term recurrence rate of pleomorphic adenoma and postoperative facial nerve paresis (in parotid surgery). J Craniomaxillofac. Surg. 2007; 35: 189-192.
 
[12]  Hancock BD. Clinically benign parotid Tumors: local dissection as an alternative to superficial parotidectomy in selected cases. Ann. R. Coll. Surg. England. 1999; 81: 299-301.
 
[13]  Makeieff M, Pelliccia P, Letois F. Recurrent pleomorphic adenoma: results of surgical treatment. Ann. Surg. Oncol. 2010; 17 (12): 3308-13.
 
[14]  McGurk M, Renehan A, Gleave EN. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenoma. Br. J Surg. 1996; 83 (12): 1747-9.
 
[15]  Dell’Aversana Orabona G, Bonavolontà P, Iaconetta G. Surigical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy –our experience in 232 cases. J Oral Maxillofac. Surg. 2013; 71(2):410-3.
 
[16]  Klinsworth N, Zrok J, Koch M. Postoperative complications after extracapsular dissection of benign parotid lesions with particular reference to facial nerve function. Laryngoscope. 2010; 120, 484-90.
 
[17]  Witt R. The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope 2002; 112: 2141-5.